ArticleCardiovascular diabetology. Endocrinology reports2026
Safety of SGLT2 inhibitors versus DPP-4 inhibitors in super-elderly patients (≥ 80 years) with type 2 diabetes: a propensity score-matched cohort study.
Shankar Biswas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.